Portfolio Building Block World Pharma and Biotech Index ETF
PBPH
11 hedge funds and large institutions have $732M invested in Portfolio Building Block World Pharma and Biotech Index ETF in 2026 Q1 according to their latest regulatory filings, with 11 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
83,114% more capital inflows, than outflows
Capital inflows: $746M | Capital outflows: $896K
1,000% more funds holding
Funds holding: 1 → 11 (+10)
1,000% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 1
102.76% more ownership
Funds ownership: 0.13% → 102.88% (+103%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fisher Asset Management
Camas,
Washington
|
+$730M |
| 2 |
Jane Street
New York
|
+$12.3M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.56M |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$48K |
| 5 |
Key Financial Inc
West Chester,
Pennsylvania
|
+$29.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$896K |
PBPH Hedge Fund Activity: Q1 2026 in Review
11 of the 8,232 institutional investors tracked by Wall St. Rank reported a position in Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) for Q1 2026, worth a combined $732M — up 81,594% from $896K a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new PBPH positions and 1 closed out — a net gain of 10 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Fisher Asset Management, opening a new position worth an estimated $730M. The largest seller was Citadel Advisors, exiting entirely with an estimated $896K sold.
- 11 institutional investors held Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) as of Q1 2026, up from 1 in Q4 2025.
- Funds reported $732M of Portfolio Building Block World Pharma and Biotech Index ETF stock for Q1 2026, up 81,594% quarter-over-quarter.
- 11 funds opened new Portfolio Building Block World Pharma and Biotech Index ETF positions in Q1 2026 and 1 closed out, a net change of +10 holders.
- The largest Portfolio Building Block World Pharma and Biotech Index ETF buyer in Q1 2026 was Fisher Asset Management, an estimated $730M added.
- The largest Portfolio Building Block World Pharma and Biotech Index ETF seller in Q1 2026 was Citadel Advisors, an estimated $896K sold.
Based on aggregated 13F filings for Q1 2026.